On Friday 17th October, the European Society for Medical Oncology’s Annual Meeting 2025 kicked off, with the opening press ...
A recent report from the Congressional Budget Office found no evidence that savings from the 340B program are passed on to ...
UCB's experimental medicine for rare disease thymidine kinase 2 deficiency (TK2d) has been shown to reduce the risk of death ...